Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MOXIS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
38770747 ADC 2 (DAR 4)
|
|||||
| Synonyms |
ADC 2
Click to Show/Hide
|
|||||
| Organization |
AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, USA.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||